USA Archives

Phase 3 Drug Candidates – A Ray of Hope in Alzheimer’s Disease Bleak Treatment Landscape?

26/09/2024by EOS Intelligence

Many biopharmaceutical companies, such as AriBio, Annovis Bio, Athira Pharma, Cassava Sciences, and Alzheon, specializing in treating neurodegenerative diseases, are developing drugs for Alzheimer’s disease (AD) that are currently in...

Pharma Companies Navigate Their Way through Ac-225 amidst Supply Constraints

19/09/2024by EOS Intelligence

Pharma companies have been increasingly investing in developing targeted alpha therapies for cancer treatment, using alpha-emitting isotopes such as Ac-225. However, the current supply for Ac-225 is limited, and thus,...

IRA: Are Patients Winning at the Cost of the US Pharma Sectoral Growth?

20/06/2024by EOS Intelligence

The market reaction to the US Inflation Reduction Act of 2022 is mostly mixed. It is expected to change the pharma industry dynamics in terms of the competitive positioning and...

The Rise and Fall of Cue Health: Market Lessons and Implications

13/06/2024by EOS Intelligence

Cue Health, the portable COVID-19 test maker, reached its zenith during the pandemic’s peak, securing investments and contracts from both government and private sectors. The company was lauded for its...

An Era of Innovation: Novel Drugs Redefining Multiple Sclerosis Treatment Paradigm

30/05/2024by EOS Intelligence

Since the approval of the first drug, interferon beta 1b (IFNβ-1b), in 1993, the treatment landscape of multiple sclerosis (MS) has significantly changed. Currently, there exist more than 20 disease-modifying...

The Promise of Comprehensive Genomic Profiling in the USA

02/05/2024by EOS Intelligence

Comprehensive Genomic Profiling (CGP) is a diagnostic tool that sequences a patient’s tumor DNA to identify genetic mutations that drive cancer growth. Insurance coverage for CGP varies widely depending on...

PFA – A Potential Paradigm Shift in Atrial Fibrillation Ablation Landscape

11/04/2024by EOS Intelligence

Pulsed Field Ablation (PFA) is an emerging technology for treating atrial fibrillation (AFib), a form of irregular heartbeat affecting 40 million heart patients worldwide as of 2023. As the prevalence...

Digital Therapeutics: The Future of Healthcare?

21/03/2024by EOS Intelligence

Although the COVID-19 pandemic seems to be done with its rampage, many people still opt to access all kinds of services, including healthcare, from the comfort of their homes. As...

Who We Are

Connect With Us

Work With EOS